MedTrace Logo

A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

NCT05384314 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2022-05-20

No results posted yet for this study

Summary

A retrospective study to evaluate the predictability of abnormal arterial blood gas measurements through novel observations of continuous trends in electronically measured respiratory in a mixed cohort of respiratory compromised patients.

Conditions

Interventions

DEVICE

RespiraSense

The use of continuous electronic monitoring of respiratory rate

Sponsors & Collaborators

  • Beaumont Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2022-10-12
Completion
2022-12-12

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05384314 on ClinicalTrials.gov